144 related articles for article (PubMed ID: 37467700)
1. MOG-specific T cell response amplified in para- and post-SAR-CoV-2 infection in myelin oligodendrocyte glycoprotein antibody-associated disease.
Wu Q; Thakolwiboon S; Ali AS; Wang Q; Dwyer D; Fox DA; Mao-Draayer Y
J Neuroimmunol; 2023 Sep; 382():578143. PubMed ID: 37467700
[TBL] [Abstract][Full Text] [Related]
2. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a COVID-19 patient: A case report.
Kogure C; Kikushima W; Fukuda Y; Hasebe Y; Takahashi T; Shibuya T; Sakurada Y; Kashiwagi K
Medicine (Baltimore); 2021 May; 100(19):e25865. PubMed ID: 34106635
[TBL] [Abstract][Full Text] [Related]
3. Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review.
Bosello F; Marastoni D; Pizzini FB; Zaffalon C; Zuliani A; Turri G; Mariotto S; Bonacci E; Pedrotti E; Calabrese M
J Neuroimmunol; 2023 Feb; 375():578011. PubMed ID: 36621074
[TBL] [Abstract][Full Text] [Related]
4. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Encephalomyelitis and Optic Neuritis After COVID-19 Vaccination and Relapsing Optic Neuritis After COVID-19 Infection.
Huang KI; Cheng CK; Peng PH
J Neuroophthalmol; 2024 Jun; 44(2):e219-e221. PubMed ID: 36857140
[No Abstract] [Full Text] [Related]
5. SARS-CoV-2-related Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Case Report and Literature Review.
Ide T; Kawanami T; Eriguchi M; Hara H
Intern Med; 2022 Apr; 61(8):1253-1258. PubMed ID: 35135920
[TBL] [Abstract][Full Text] [Related]
6. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-COVID-19 infection patient.
Zaini MA; Mohd Zain A; Md Din N; Lam C
Immun Inflamm Dis; 2023 Oct; 11(10):e1051. PubMed ID: 37904693
[TBL] [Abstract][Full Text] [Related]
7. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.
Jarius S; Bieber N; Haas J; Wildemann B
J Neurol; 2022 Oct; 269(10):5198-5212. PubMed ID: 35737110
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of serum MOG antibody and AQP4 antibody in optic neuritis after SARS-CoV-2 infection.
Sun CB
Front Immunol; 2023; 14():1296518. PubMed ID: 38054007
[TBL] [Abstract][Full Text] [Related]
9. MOG-IgG positive optic neuritis after SARS-CoV-2 infection.
Gilardi M; Cortese A; Ferraro E; Rispoli M; Sadun R; Altavista MC; Sadun F
Eur J Ophthalmol; 2023 Sep; 33(5):NP87-NP90. PubMed ID: 36317310
[TBL] [Abstract][Full Text] [Related]
10. SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder.
Johnsson M; Asztely F; Hejnebo S; Axelsson M; Malmeström C; Olausson T; Lycke J
Ann Clin Transl Neurol; 2022 Aug; 9(8):1296-1301. PubMed ID: 35713508
[TBL] [Abstract][Full Text] [Related]
11. COVID-19-Induced Acute Bilateral Optic Neuritis.
Sawalha K; Adeodokun S; Kamoga GR
J Investig Med High Impact Case Rep; 2020; 8():2324709620976018. PubMed ID: 33238757
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.
Kezuka T; Ishikawa H
Jpn J Ophthalmol; 2018 Mar; 62(2):101-108. PubMed ID: 29445944
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
[TBL] [Abstract][Full Text] [Related]
14. Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series.
Lambe J; McGinley MP; Moss BP; Mao-Draayer Y; Kassa R; Ciotti JR; Mariotto S; Kunchok A
J Neuroimmunol; 2022 Sep; 370():577933. PubMed ID: 35878436
[TBL] [Abstract][Full Text] [Related]
15. Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review.
Tanaka K; Kezuka T; Ishikawa H; Tanaka M; Sakimura K; Abe M; Kawamura M
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686172
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.
Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802
[TBL] [Abstract][Full Text] [Related]
17. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
[TBL] [Abstract][Full Text] [Related]
18. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis.
Tsuburaya RS; Miki N; Tanaka K; Kageyama T; Irahara K; Mukaida S; Shiraishi K; Tanaka M
Brain Dev; 2015 Jan; 37(1):145-8. PubMed ID: 24582475
[TBL] [Abstract][Full Text] [Related]
19. [A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis].
Nagata S; Nishimura Y; Mitsuo K
Rinsho Shinkeigaku; 2018 Oct; 58(10):636-641. PubMed ID: 30270341
[TBL] [Abstract][Full Text] [Related]
20. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis and Myelitis in COVID-19.
Zhou S; Jones-Lopez EC; Soneji DJ; Azevedo CJ; Patel VR
J Neuroophthalmol; 2020 Sep; 40(3):398-402. PubMed ID: 32604245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
